Why the study?
Sarcopenia and diabetes contribute to frailty, creating a need for accessible methods like muscle ultrasound to screen for sarcopenia in clinical practice.
Does muscle ultrasound correlate with other measures of sarcopenia and predict sarcopenia in frail elderly patients with diabetes?
Cross-Sectional (n=47)
Does muscle ultrasound correlate with other measures of sarcopenia and predict sarcopenia in frail elderly patients with diabetes?
Muscle ultrasound is a feasible tool that correlates with bioimpedance analysis and can help identify regional sarcopenia in frail elderly patients with diabetes.
Answers are grounded in this paper and cite their sources.
May support bedside sarcopenia screening in frail diabetic elderly; hypothesis-generating and requires prospective validation before practice change.
Background: Sarcopenia and diabetes contribute to the development of frailty. Therefore, accessible methods, such as muscle ultrasounds (MUSs), to screen for sarcopenia should be implemented in clinical practice. Methods: We conducted a cross-sectional pilot study including 47 patients with diabetes (mean age: 77.72 ± 5.08 years, mean weight: 75.8 kg ± 15.89 kg, and body mass index: 31.19 ± 6.65 kg/m2) categorized as frail by the FRAIL Scale or Clinical Frailty Scale and confirmed by Fried’s Frailty Phenotype or Rockwood’s 36-item Frailty Index. We used the SARC-F questionnaire to identify sarcopenia. The Short Physical Performance Battery (SPPB) and the Timed Up and Go (TUG) tests were used to assess physical performance and the risk of falls, respectively. In addition, other variables were measured: fat-free mass (FFM) and Sarcopenia Risk Index (SRI) with the bioimpedance analysis (BIA); thigh muscle thickness (TMT) of the quadriceps with MUS; and hand-grip strength with dynamometry. Results: We observed correlations between the SARC-F and FFM (R = −0.4; p < 0.002) and hand-grip strength (R = −0.5; p < 0.0002), as well as between the TMT and FFM of the right leg (R = 0.4; p < 0.02) and the SRI (R = 0.6; p < 0.0001). We could predict sarcopenia using a logistic regression model with a ROC curve (AUC = 0.78) including FFM, handgrip strength, and TMT. The optimal cut-off point for maximum efficiency was 1.58 cm for TMT (sensitivity = 71.4% and specificity = 51.5%). However, we did not observe differences in the TMT among groups of greater/less frailty based on the SARC-F, SPPB, and TUG (p > 0.05). Conclusions: MUSs, which correlated with the BIA (R = 0.4; p < 0.02), complemented the diagnosis, identifying regional sarcopenia of the quadriceps in frail patients with diabetes and improving the ROC curve to AUC = 0.78. In addition, a TMT cut-off point for the diagnosis of sarcopenia of 1.58 cm was obtained. Larger studies to validate the MUS technique as a screening strategy are warranted.
No takes yet. Share an insight, caveat, or question.
Simó-Servat et al. (2023) conducted a cross-sectional in Frailty and diabetes (n=47). Muscle ultrasound (MUS) for thigh muscle thickness (TMT) was evaluated on Prediction of sarcopenia using a logistic regression model including fat-free mass, handgrip strength, and thigh muscle thickness (AUC 0.78).
Synapse has enriched 10 related papers. Consider them for comparative context: